Screener
Adaptive Biotechnologies ADPT Gross margin
Gross margin at other companies
Other financials
Where this comes from
Calculated from Adaptive Biotechnologies’s reported figures.
Based on trailing twelve months.
The source filing: Adaptive Biotechnologies’s 10-Q, filed May 5, 2026. Open the filing →
- Filed
- May 5, 2026, 4:30 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-206546
FAQ
- What is Adaptive Biotechnologies's gross margin?
- Adaptive Biotechnologies (ADPT) reported gross margin of 75.3% in Q1 2026.
- How has Adaptive Biotechnologies's gross margin changed year-over-year?
- Adaptive Biotechnologies's gross margin increased by 20.3% year-over-year, from 62.5% to 75.3%.
- What is the long-term trend for Adaptive Biotechnologies's gross margin?
- Over 5 years (2020 to 2025), Adaptive Biotechnologies's gross margin has grown at a -0.8% compound annual growth rate (CAGR), from 77.1% to 74.2%.
- What does gross margin mean?
- Gross profit (revenue minus cost of revenue) as a percentage of revenue, on a trailing-twelve-month basis. Measures how much of each sales dollar survives the direct cost of producing the goods or services sold.
Ask your AI about Adaptive Biotechnologies's gross margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude